Logo Lanfrica

Brief Report: Should Abacavir Be a First-Line Alternative for Adults With HIV in Sub-Saharan Africa?

Domaine:

healthcare

Type de record:

paper
Créateur:
GuiSuzYapPet
Éditeur:
Ovi
Hôte:
Abstract: Despite a poor toxicity profile, zidovudine supersedes abacavir (ABC) as an alternative first-line agent in most international treatment guidelines because of concerns about HLA-B*57:01-related ABC-hypersensitivity. We detected one case of HLA-B*57:01 carriage among 513 HIV-infected individuals in Uganda, which, in combination with previous reports, supports the safety of ABC in the region.

Similaires

What Should be the Focus of Agricultural Policy Reforms in Sub-Saharan Africa? A CGE Analysis

While a lot of research has been conducted on agricultural subsidies and other forms of policy trans

Protease Inhibitor Resistance in the First 3 Years of Second-Line Antiretroviral Therapy for HIV-1 in Sub-Saharan Africa

Background.
As antiretroviral therapy (ART) programs in sub-Saharan Africa mature, increasing n

Screening tools for HIV-associated neurocognitive disorders among adults living with HIV in sub-Saharan Africa: A scoping review

Background : People living with HIV are at risk of developing HIV-associated ne

Perceptions of Social Support Sufficiency Among Older Adults With HIV in Sub-Saharan Africa

Abstract Globally, the greatest number of older people with HIV (OPWH) are in sub-S

Should Digital Interventions for HIV Self-Testing Be Regulated with World Health Organization Prequalification?

Abstract HIV self-testing (HIVST) allows people to test for HIV outside traditional heal

Brief Report: Stigma and HIV Care Continuum Outcomes Among Ethiopian Adults Initiating ART

Background: Stigma harms the mental health of HIV-positive individuals and reduces adh